Ischemic preconditioning attenuates cardiac sympathetic nerve injury via ATP-sensitive potassium channels during myocardial ischemia

Circulation

Volumn 104, Issue 9, 2001, Pages 1053-1058

  Miura, Toshiro ^a   Kawamura, Shuji ^a   Tatsuno, Hironari ^a   Ikeda, Yasuhiro ^a   Mikami, Shunsuke ^a   Iwamoto, Hiroshi ^a   Okamura, Takayuki ^a   Iwatate, Mitsuo ^a   Kimura, Masayasu ^a   Dairaku, Yuka ^a   Maekawa, Tsuyoshi ^a   Matsuzaki, Masunori ^a  

^a YAMAGUCHI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Ion channels; Ischemia; Nervous system, sympathetic; Norepinephrine

Indexed keywords

GLIBENCLAMIDE; NICORANDIL; NORADRENALIN; POTASSIUM CHANNEL; POTASSIUM CHANNEL STIMULATING AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIALYSATE; DOG; HEART INFARCTION PREVENTION; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PROTECTION; MICRODIALYSIS; NERVE INJURY; NONHUMAN; NORADRENALIN RELEASE; PATHOGENESIS; PRIORITY JOURNAL; SYMPATHETIC NERVE;

EID: 0035964414     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/hc3501.093800     Document Type: Article

References (35)

1. Preconditioning with ischemia: A delay of lethal cell injury in ischemic myocardium
2. 1 adenosine receptors in rabbit heart
3. Adenosine and the anti-infarct effects of preconditioning
4. α-adrenoceptor stimulation with exogenous norepinephrine or release of endogenous catecholamines mimics ischemic preconditioning
5. 1-adrenergic mechanism
6. 2 receptor activation
7. Role of bradykinin in protection of ischemic preconditioning in rabbit hearts
8. Pretreatment with angiotensin II activates protein kinase C and limits myocardial infarction in isolated rabbit hearts
9. Preconditioning protects ischemic rabbit heart by protein kinase C activation
10. Involvement of activation of ATP-dependent potassium channels in ischemic preconditioning in swine
11. Limitation of infarct size in the rabbit by ischaemic preconditioning is reversible with glibenclamide
12. Blockade of ATP-sensitive potassium channels prevents myocardial preconditioning in dogs
13. Nonexocytotic release of endogenous noradrenaline in the ischemic and anoxic rat heart: Mechanism and metabolic requirements
14. Release of endogenous catecholamine in the ischemic myocardium of the rat, A: Locally mediated release
15. Transient ischemia reduces norepinephrine release during sustained ischemia: Neural preconditioning in isolated rat heart
16. Intermittent vs continuous ischemia decelerates adenylate breakdown and prevents norepinephrine release in reperfused rabbit heart
17. Influence of the force-frequency relation on left ventricular function during exercise in conscious dogs
18. Measurement of regional myocardial blood flow with multiple colored microspheres
19. Catecholamine measurements in plasma by high-performance liquid chromatography with electrochemical detection
20. Simultaneous multiple electrode liquid chromatographic electrochemical assay for catecholamines, indoleamines and metabolites in brain tissue
21. In vivo monitoring of myocardial interstitial norepinephrine by dialysis technique
22. + channels in substantia nigra
23. + channels and block neurosecretion
24. + channel activators and inhibitors in human isolated right atrium
25. An inhibitory effect of verapamil and diltiazem on the release of noradrenaline from ischaemic and reperfused hearts
26. 1 adenosine receptor, lowers the threshold for ischemic preconditioning in dogs
27. Intracoronary administration of the alpha 1-receptor agonist, methoxamine, does not reproduce the infarct-limiting effect of ischemic preconditioning in dogs
28. Adenosine deaminase inhibition augments interstitial adenosine but does not attenuate myocardial infarction
29. The cardioprotective effects of ischemic preconditioning are not mediated by adenosine receptors in rat heart
30. Reperfusion after brief ischemia disrupts the microtubule network in canine hearts
31. The deleterious effects of myocardial catecholamines on cellular electrophysiology and arrhythmias during ischemia and reperfusion
32. Sympatho-adrenergic activation of the ischemic myocardium and its arrhythmogenic impact
33. PKA phosphorylation dissociates FKBP 12.6 from the calcium release channel (ryanodine receptor): Defective regulation in falling hearts
34. Extent of cardiac sympathetic neuronal damage is determined by the area of ischemia in patients with acute coronary syndromes
35. 99mTc-MIBI and late ventricular potentials in patients after myocardial infarction: Association with the development of ventricular arrhythmias